Kader Thiam

Kader Thiam

Company: GenOway

Job title: Vice President - Transgenic Technologies & Director - Business Development


Assessment of Biologics’ Efficacy Using Preclinical Models Featuring Humanized Immune Checkpoint Models or Stem Cell-Reconstituted Immunodeficient Mice 4:00 pm

• Understanding the breakthrough of immunotherapy for the success of cancer therapy • Exploring why there are subsets of patients, which do not show robust response to immunotherapy • Navigating the limitations of immuno-oncology to ensure preclinical models recapitulate the complexity of the etiology of tumors • Exploring how immune checkpoint models as well humanized…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.